Inventive Proteomics offers iTRAQ protein evaluation benefit suited for unprejudiced untargeted biomarker revelation. Relative measurement of proteins for biomarker disclosure in complex blends by mass spectrometry can without much of a stretch and rapidly be accomplished utilizing iTRAQ innovation. iTRAQ is in a perfect world suited for looking at typical, infected, and sedate treated examples, time course examines, organic recreates and gives relative quantitation. Protein evaluation through consolidation of stable isotopes has turned into a focal innovation in advanced proteomics explore. Isobaric labels for relative and supreme quantitation (iTRAQ) is utilized as a part of proteomics to examine quantitative changes in the proteome. iTRAQ-based measurement encourages the similar examination of peptide and proteins in an assortment of settings including correlation of ordinary, ailment or medication treated states. The iTRAQ innovation uses isobaric reagents to mark the essential amines of peptides and proteins. The iTRAQ reagents as a rule comprise of a N-methyl piperazine correspondent gathering, an adjust aggregate, and a N-hydroxy succinimide ester assemble that is responsive with the essential amines of peptides. The adjust bunches show in each of the iTRAQ reagents capacity to make the marked peptides from every example isobaric and the measurement is encouraged through examination of correspondent gatherings that are created upon discontinuity in the mass spectrometer. There are at present two principally utilized reagents: 4-plex and 8-plex, which can be utilized to mark all peptides from various specimens/medications. These specimens are then pooled and typically fractionated by nano fluid chromatography and dissected by pair mass spectrometry (MS/MS).